Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've searched for Mounjaro 5mg offers, the honest answer is this: Mounjaro is a prescription-only medicine, which means any legitimate supply requires a clinical assessment by a qualified prescriber — no matter the price. The 5mg pen is the first dose increase after the starter pen, and understanding what it means for your treatment matters far more than any headline deal. Mounjaro (tirzepatide) works by activating two gut-hormone receptors involved in appetite regulation and blood-sugar control. That mechanism doesn't change at 5mg — but your body's response to the step up might. Here's what the clinical picture actually looks like at this stage.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 2.5mg starting dose isn't designed to drive significant weight loss. Its job is to let your body adjust to tirzepatide before the dose rises. Think of it as a settling-in period rather than treatment in full. The 5mg pen is where the therapeutic intent sharpens. At this dose, appetite suppression tends to become more noticeable, gastric emptying slows more meaningfully, and most people begin to see clearer changes in how hungry they feel between meals.
From a clinical standpoint, this step also tests tolerability at a higher level. The NHS medicines page for tirzepatide explains the full dose range (2.5mg through to 15mg) and describes how the titration schedule is intended to minimise side effects while building towards a clinically effective maintenance dose. Your prescriber, not a protocol printed on the box, decides when and whether you move from 2.5mg to 5mg. That clinical judgement depends on how well you've tolerated the starter pen and what your overall health picture looks like.
It's worth saying plainly: people who rush to higher doses in search of faster results tend to have a worse time. The stepped schedule exists for a reason, and patience at 5mg often pays dividends at the doses that follow. If you're thinking about starting treatment, learning what to expect at the 2.5mg stage first gives you a grounded picture of the journey ahead.
Nausea is the one most people mention. It's not universal, but it's common, and it's usually most pronounced in the first week after stepping up. Vomiting, loose stools or constipation, indigestion and burping all appear in clinical reports at this dose. Fatigue and mild headaches are also reported, particularly in the early days after an increase. Most of this settles. The key is not to interpret the discomfort as a sign that the medicine isn't working or that something has gone wrong, for the majority of people, it's just the system adjusting.
What you do need to act on promptly is severe or persistent abdominal pain, especially pain that radiates through to your back. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis as an infrequent but serious risk, the Yellow Card reporting scheme is where suspected side effects, including anything that concerns you, can be reported directly to the MHRA. Other symptoms to treat as urgent: signs of a severe allergic reaction, gallbladder pain, or significant dehydration from vomiting or diarrhoea.
Injection-site reactions are also more common than people expect. Rotating the site between your abdomen, thigh and upper arm at each weekly dose makes a practical difference. Full detail on what to watch for is in the Patient Information Leaflet inside the box, the pen comes in plain, unbranded packaging via tracked DPD delivery, and that leaflet is your most important first read.
This is where it's worth being direct. Mounjaro is a Prescription-Only Medicine. The legitimate private market has a fairly well-defined price range, following Eli Lilly's list-price increase in September 2025, typical private prices for Mounjaro have been reported in the range of roughly £149 to £375 per month depending on dose and provider. A price far below that floor, especially with a discount code attached, is a reason to ask questions rather than click checkout.
The MHRA has warned explicitly about counterfeit weight-loss pens sold online and through social media, some fake pens seized in enforcement operations contained insulin rather than tirzepatide, with serious consequences for patients who used them. You can verify any online pharmacy on the GPhC register in about thirty seconds. A legitimate pharmacy will have a registered premises number you can look up. At nume, our GPhC premises registration (9012878) is verifiable there directly. For a full breakdown of what private treatment pricing typically covers (and what it sometimes doesn't) this page on what a genuine 5mg offer should include is worth reading before you decide anywhere.
The short version: for a prescription medicine, safety is the metric that matters. A small saving on the pen price isn't a saving if the supply chain is unknown.
Dose progression isn't automatic. A prescriber considering whether to move you from 2.5mg to 5mg will want to understand how you tolerated the starter dose, specifically whether side effects were manageable and whether you've had no new contraindications emerge. They'll look at your current weight alongside your starting weight, your general health, and any medicines you're taking alongside Mounjaro. If you want to read ahead, our page on the Mounjaro 5mg pen covers what this stage of treatment involves in practical terms.
One aspect that catches people off guard involves oral contraceptives. Because tirzepatide slows gastric emptying, it can temporarily reduce the absorption of a pill taken at the same time. UK guidance recommends adding a barrier method (such as condoms) for the first four weeks of treatment and for four weeks after each dose increase, including the step to 5mg. If you're using HRT, transdermal forms such as patches or gels may be preferable; it's worth raising this with whoever manages your HRT. These conversations belong with your prescriber, not an FAQ page, but knowing to raise them is half the battle. For those already at 5mg and thinking about what comes next, our page on the Mounjaro 7.5mg pen sets out what that subsequent step typically looks like. The full clinical picture at the 5mg dose level covers these considerations in more depth.
At nume, a named prescriber (a GPhC-registered Independent Prescriber) reads your consultation personally before any treatment is approved or a dose increase is confirmed. If you're considering starting or stepping up your treatment, starting a free consultation is the appropriate next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.